The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis

Background: Despite meticulous surgery for non-small cell lung cancer (NSCLC), relapse is as high as 70% at 5 years. Many institutions do not conduct reflexive molecular testing on early stage specimens, although targeted gene therapy may extend life by years in the event of recurrence. This ultimat...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Anna L., McConechy, Melissa K., Melosky, Barb L., English, John C., Choi, James J., Peng, Defen, Yee, John, Furman, Benjamin L. S., Aguirre Hernandez, Rosalia, Feijao, Pedro, Mulder, David, Hughesman, Curtis, Yip, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031556/
https://www.ncbi.nlm.nih.gov/pubmed/35448189
http://dx.doi.org/10.3390/curroncol29040215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031556/
https://www.ncbi.nlm.nih.gov/pubmed/35448189
http://dx.doi.org/10.3390/curroncol29040215

Ejemplares similares